亚洲 · 区域市场 · Moneycontrol
Biocon banks on new biosimilar launches, insulin franchise to drive stronger H2 FY27
According to Chief Executive Officer and Managing Director Shreehas Tambe, around $20 million (around Rs.200 crore) of quarterly biosimilars revenue could not be recognised in Q2…
在 Moneycontrol 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.moneycontrol.com)
